Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations


   0 (0%) 12-31 19:00
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0(M)

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.28 - 11.36 11.36 - 11.42
Low: 11.04 - 11.12 11.12 - 11.18
Close: 11.09 - 11.21 11.21 - 11.31

Technical analysis

as of: 2022-09-30 4:29:58 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 14.36     One year: 15.16
Support: Support1: 11.19    Support2: 9.31
Resistance: Resistance1: 12.29    Resistance2: 12.97
Pivot: 11.61
Moving Average: MA(5): 11.25     MA(20): 11.73
MA(100): 12.54     MA(250): 13.74
MACD: MACD(12,26): -0.4     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 4.6     %D(3): 5.4
RSI: RSI(14): 16.8
52-week: High: 16.51  Low: 11.19
Average Vol(K): 3-Month: 20 (K)  10-Days: 20 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MNP ] has closed above bottom band by 16.2%. Bollinger Bands are 48.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

Headline News

Tue, 19 Feb 2019
Immune Pharmaceuticals Files for Chapter 11 Protection - GlobeNewswire

Tue, 27 Nov 2018
Immune Pharmaceuticals and Vector Therapeutics Sign Option Agreement for Worldwide CepleneĀ® Rights - GlobeNewswire

Thu, 26 Jul 2018
Immune Pharmaceuticals Receives Nasdaq Delisting Determination; Eligible to trade Over-the-Counter July 26, 2018 - GlobeNewswire

Wed, 23 May 2018
Immune Pharmaceuticals Provides a Pipeline Update - GlobeNewswire

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. 10 (M)
Shares Float 0 (M)
% Held by Insiders 0 (%)
% Held by Institutions 30 (%)
Shares Short 12 (K)
Shares Short P.Month 5 (K)

Stock Financials

EPS 0.69
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 16.7
Profit Margin (%) 106.4
Operating Margin (%) 70.5
Return on Assets (ttm) 1.4
Return on Equity (ttm) 4.8
Qtrly Rev. Growth -4.7
Gross Profit (p.s.) 0.86
Sales Per Share 0.86
EBITDA (p.s.) 0
Qtrly Earnings Growth -90.6
Operating Cash Flow 4 (M)
Levered Free Cash Flow 9 (M)

Stock Valuations

PE Ratio 16
PEG Ratio 0
Price to Book value 0.67
Price to Sales 13
Price to Cash Flow 29.34

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2019-02-28
Ex-Dividend Date 2022-01-20
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.